RAI Services Company
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, RAI Services Company sits in the top decile of US sponsors by registered trial count (#420 of 15,742 sponsors by registered trial count).
RAI Services Company: 42 sponsored US clinical trials, 2 recruiting.
RAI Services Company sponsors 42 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 39 completed. The most-studied condition in this pipeline is Smoking, with 9 trials.
Top-decile sponsor footprint
RAI Services Company ranks in the top decile of sponsors by registered trial count (#420 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
39 of 40 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
42 total, page 1 of 1
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
NCT07598136
Abuse Liability for Five Modern Oral Nicotine Products
NCT07132814
A RCT to Determine the Effect of ENDS Flavor Availability on Abstinence Within Smokers
NCT07172438
Modern Nicotine Oral Product Abuse Liability
NCT06777784
CSD231005 Nicotine Pouch Biomarkers of Exposure
NCT06303115
CSD201204 An Actual Use Study of P12 Electronic Nicotine Delivery System Among U.S. Adult Smokers
NCT05960305
CSD200902: Assessment of Indoor Air Quality for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Environmental Testing Chamber
NCT05363254
CSD201301: Study to Assess Elements of Abuse Liability for Four P13 Nicotine Pouches
NCT05294497
CSD210903: A Study to Determine Subject Puffing Patterns of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in an Ambulatory Setting
NCT05307822
CSD201201: Study to Assess Elements of Abuse Liability for Electronic Nicotine Delivery System P12
NCT05210699
CSD201202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery System P12
NCT05239884
CSD201203: A Study to Determine Subject Puffing Patterns of a Non-cylindrical, Closed, Electronic Nicotine Delivery System at Three Nicotine Concentrations in an Ambulatory Setting
NCT05118139
CSD201004: An Actual Use Study of P10 and P13 Nicotine Pouches Among U.S. Adult Smokers
NCT05184920
CSD200907: A Study to Assess Elements of Abuse Liability for a Heated Tobacco Product With Four Non-Combusted Cigarette Variants
NCT05114863
CSD201001: Study to Assess Elements of Abuse Liability for Three Nicotine Pouches
NCT05129657
CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers
NCT05102786
CSD201002: Study to Assess Nicotine Uptake From P10 Nicotine Pouches
NCT05081154
CSD210202: A Study to Assess Nicotine Uptake From Electronic Nicotine Delivery Systems
NCT04751461
CSD190601: A Study to Determine Subject Puffing Patterns of Electronic Nicotine Delivery Systems in an Ambulatory Setting
NCT04308434
CSD190401: A Study to Assess Elements of Abuse Liability for Nicotine-containing Pouch Tobacco Products
NCT04372290
CSD190501: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting
NCT04226404
CSD190301: A Study to Assess Elements of Abuse Liability for Two Dissolvable Nicotine Lozenge Tobacco Products
NCT04167384
CSD190203: A Study to Determine Subject Puffing Patterns of an Electronic Nicotine Delivery System in an Ambulatory Setting
NCT04104152
CSD190202: Study to Assess Elements of Abuse Liability for Two Electronic Nicotine Delivery Systems
NCT04094363
CSD190101: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products
NCT03993769
CSD190103: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products
NCT03993795
CSD190102: A Study to Assess Nicotine Pharmacokinetic Parameters After Use of Two Smokeless Tobacco Products
NCT03993782
BRP1802 Smoking Abstinence Study
NCT04979013
CSD1805: Study to Assess Nicotine Uptake and Product Use Behavior in Moist Snuff Consumers Using Two Moist Snuff Products
NCT03688776
CSD170304: Study to Assess Nicotine Uptake in Smokers From Electronic and Combustible Cigarettes
NCT03294356
CSD170302: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
NCT03233997
CSD170303: Study to Assess Nicotine Uptake in Smokers From Electronic Cigarettes
NCT03234010
CSD170501: Study to Assess Biomarkers of Tobacco Exposure in Smokers During In-Clinic Confinement Switch to an Electronic Cigarette
NCT03170674
CSD170202: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products
NCT03158428
CSD170201: A Study to Evaluate the Exposure to Tobacco Constituents From Two Moist Snuff Products
NCT03153761
CSD170401: Study to Assess Elements of Abuse Liability for Three Electronic Tobacco Vapor Products During an 11-Day In-Clinic Confinement
NCT03126357
CSD170301: An Unblinded, Parallel, Randomized Study to Assess Nicotine Uptake in Smokers From Four Different Electronic Cigarettes
NCT03105804
CSD1603: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From 100s Menthol Cigarette Products
NCT03063047
CSD1602: A Crossover Study to Evaluate the Exposure to "Tar" and Nicotine From Two King Size Menthol Cigarette Products
NCT03063034
BRP1602: Evaluation of Technical and Logistical Feasibility to Measure Lung Permeability
NCT06105424
CSD1601: A Study to Evaluate the Exposure to Tar and Nicotine From Two Cigarette Products That Contain a Menthol Capsule in the Filter
NCT04529551
Post-Market Surveillance of Tobacco Products
NCT04255459
Therapeutic Areas
What is open in the RAI Services Company pipeline
2 recruiting of 42 indexed (5% open); 39 completed (93%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Smoking (9 trials), 4 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
RAI Services Company: open-pipeline peers nationwide
Peers matched on 42 registered trials and 5% open enrollment, not the therapeutic-area sidebar.
RAI Services Company sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 42 trials (± recruiting share)
- Academic and Community Cancer Research United · 42 trials · 14% recruiting
- Ascensia Diabetes Care · 42 trials · 0% recruiting
- Avid Radiopharmaceuticals · 42 trials · 0% recruiting
- Celldex Therapeutics · 42 trials · 7% recruiting
Sponsors near 5% open enrollment (± trial volume)
- Amphastar Pharmaceuticals · 5% recruiting · 21 trials
- Cook County Health · 5% recruiting · 21 trials
- David Grant U.S. Air Force Medical Center · 5% recruiting · 21 trials
- Duquesne University · 5% recruiting · 21 trials
Related
What to do with this RAI Services Company page
42 registered trials is a research-attention snapshot, not an endorsement of RAI Services Company or any single study.
- 2 of RAI Services Company's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Smoking is the condition RAI Services Company studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Smoking trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
RAI Services Company pipeline card: 42 registered trials from official public datasets.Report a data error.